DePuy ASR Lawsuit Settlement Program Moves Forward, as Johnson & Johnson Waives “Walk Away” Rights, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing numerous DePuy ASR recall clients who are eligible to participate in the DePuy ASR settlement program.

Free Case Review
Our Firm is representing a number of DePuy ASR recall clients who are eligible to participate in the settlement program. We are pleased that implementation of the program is moving forward,

The federal court overseeing thousands of DePuy ASR hip lawsuits ( continues to move closer to the implementation of a proposed settlement program announced last year, Bernstein Liebhard LLP reports. According to a Notice issued in the U.S. District Court, Northern District of Ohio on May 20, 2014, Johnson & Johnson has waived its “walk away” rights, as a majority of eligible claimants have opted to participate in the DePuy ASR settlement program. As such, plaintiffs eligible to participate in the program can expect payment since there is now certainty that the program will be moving forward. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“Our Firm is representing a number of DePuy ASR recall clients who are eligible to participate in the settlement program. We are pleased that implementation of the program is moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who may have been harmed by metal-on-metal hip implants, including those devices which were part of the 2010 DePuy ASR recall.

DePuy ASR Recall

According to court documents, DePuy Orthopaedics, a unit of Johnson & Johnson, announced the DePuy ASR recall in August 2010, after data indicated the metal-on-metal hip implants were failing prematurely in an unacceptable number of patients. Since the recall was announced, more than 12,000 DePuy ASR lawsuits have been filed in state and federal courts around the country. The DePuy ASR settlement program, which was announced in November 2013, would resolve roughly 8,000 of those claims.

According to the terms of the proposal, those eligible to participate in the DePuy ASR settlement include patients who underwent revision surgery to replace their ASR hip due to a recall-related reason prior to August 31, 2013. Eligible claimants would be entitled to a base award of $250,000. That award could be reduced, however, depending on certain other factors, including their prior medical history. Other circumstances could entitle plaintiffs to a supplemental award if they, for example, required multiple revision surgeries, or if they experience “certain extraordinary injuries” in the future. Plaintiffs who do not wish to participate, or those who are not eligible, will still be permitted to pursue individual claims against DePuy Orthopaedics and Johnson & Johnson.

Individuals who were allegedly harmed by a DePuy ASR hip implant may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a DePuy ASR lawsuit, please visit Bernstein Liebhard LLP’s website. For a free, no obligation case review, please call the Firm directly at 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website